CEOs tally health-bill score

The drug industry stands to gain in a healthcare overhaul by getting tens of millions of newly insured customers, while insurance companies look like they are in for a tougher time, according to an early scorecard from executives poring over Congress's health legislation. Senate Democrats are meeting to write the bill they plan to bring to the floor, following last week's 14-9 vote in the Senate Finance Committee for a health bill that would cost $829 billion over 10 years.